Skip to content

US CDC finds 19 percent HIV prevalence among MSM in 21-city survey

Early warning indicators for drug resistance in resource-limited settings piloted in Namibia

He's done it!

He's done it!

Russian activists arrested during treatment stock-out protests

Russian activists arrested during treatment stock-out protests

More intensive screening for TB needed for HIV-positive patients in South Africa

Truvada/Kaletra HIV PEP combination is safe and effective with a low rate of discontinuations

Aidsmap rated 'excellent' in a survey of HIV internet resources

Aidsmap rated 'excellent' in a survey of HIV internet resources

Loss to follow-up high in South African public sector ARV programmes

Where is HIV vaccine research heading?

Global HIV Vaccine Enterprise director, Dr Alan Bernstein